147 research outputs found

    A Sequential Meta-Transfer (SMT) Learning to Combat Complexities of Physics-Informed Neural Networks: Application to Composites Autoclave Processing

    Full text link
    Physics-Informed Neural Networks (PINNs) have gained popularity in solving nonlinear partial differential equations (PDEs) via integrating physical laws into the training of neural networks, making them superior in many scientific and engineering applications. However, conventional PINNs still fall short in accurately approximating the solution of complex systems with strong nonlinearity, especially in long temporal domains. Besides, since PINNs are designed to approximate a specific realization of a given PDE system, they lack the necessary generalizability to efficiently adapt to new system configurations. This entails computationally expensive re-training from scratch for any new change in the system. To address these shortfalls, in this work a novel sequential meta-transfer (SMT) learning framework is proposed, offering a unified solution for both fast training and efficient adaptation of PINNs in highly nonlinear systems with long temporal domains. Specifically, the framework decomposes PDE's time domain into smaller time segments to create "easier" PDE problems for PINNs training. Then for each time interval, a meta-learner is assigned and trained to achieve an optimal initial state for rapid adaptation to a range of related tasks. Transfer learning principles are then leveraged across time intervals to further reduce the computational cost.Through a composites autoclave processing case study, it is shown that SMT is clearly able to enhance the adaptability of PINNs while significantly reducing computational cost, by a factor of 100

    Damage Prediction in Woven and Non-woven Fabric Composites

    Get PDF
    This chapter presents a step-by-step review on different damage prediction approaches for woven and non-woven fabric composites. First, the characteristics of woven and non-woven fabrics are distinguished one from another, suggesting more complex analyses required for non-woven fabrics. Then, the subsequent sub-sections are geared toward a comparison of different approaches utilized in predicting the mechanical behavior and damage mechanisms of these composites at various material scales including micro, meso, and macro. The merits and demerits of each approach with regard to practicality, accuracy, effectiveness, and characterization expense are discussed. Moreover, using recent experimental evidences, the chapter aims to highlight a number of inherent complexities in the interlaced architecture of woven composites, which may not be precisely taken into account by the damage models originally developed for non-woven and unidirectional composites. Finally, two illustrative examples on the effect of the aforementioned complexities on the mechanical behavior of woven composites are presented in more detail, through some recent works of the authors

    An Overview of the Epidemiologic, Diagnostic and Treatment Approaches of COVID-19: What do We Know?

    Get PDF
    Background: In late December 2019, a new infectious respiratory disease (COVID-19) was reported in a number of patients with a history of exposure to the Huanan seafood market in China. The World Health Organization officially announced the COVID-19 pandemic on March 11, 2020. Here, we provided an overview of the epidemiologic, diagnostic and treatment approaches associated with COVID-19. Methods: We reviewed the publications indexed in major biomedical databases by December 20, 2020 or earlier (updated on May 16, 2021). Search keywords included a combination of: COVID-19, Coronavirus disease 2019, SARS-CoV-2, Epidemiology, Prevention, Diagnosis, Vaccine, and Treatment. We also used available information about COVID-19 from valid sources such as WHO. Results and Conclusion: At the time of writing this review, while most of the countries authorized COVID-19 vaccines for emergency use starting December 8, 2020, there is no a definite cure for it. This review synthesizes current knowledge of virology, epidemiology, clinical symptoms, diagnostic approaches, common treatment strategies, novel potential therapeutic options for control and prevention of COVID-19 infection, available vaccines, public health and clinical implications

    Cytotoxicity of Cold Ceramic compared with MTA and IRM

    Get PDF
    INTRODUCTION: Biocompatibility is a desirable feature for root-end filling materials. In this study we aimed to compare a new material called cold ceramic (CC) with intermediate restorative material (IRM) and mineral trioxide aggregate (MTA) using Methyl-tetrazolium bromide (MTT) assay. MATERIALS AND METHODS: The materials were tested in fresh and set states: (n=108). The cytotoxicity was compared using L929 fibroblasts as an indicator; tested materials were eluted with culture medium according to ISO: 109935 standard. Distilled water and culture medium served as positive and negative controls, respectively (n=36). The results were evaluated at 1, 24 hours and 7 days. Data were statistically analyzed by one-way ANOVA for each time interval and material status and t-tests. RESULTS: The cytotoxicity of the tested materials were statistically different at the various time intervals (P<0.001). IRM was the most cytotoxic root-end filling material (P<0.001), MTA demonstrated the least cytotoxicity followed by CC.  CONCLUSION: Despite displaying the greatest cytotoxicity, IRM is approved by the American Food and Drug Administration (FDA). Cold ceramic had significantly lower cytotoxicity compared to IRM, in all but one subgroup. Further investigations are required to assess the clinical applicability of this novel material

    A meta-analysis of gene expression signatures of blood pressure and hypertension.

    Get PDF
    Genome-wide association studies (GWAS) have uncovered numerous genetic variants (SNPs) that are associated with blood pressure (BP). Genetic variants may lead to BP changes by acting on intermediate molecular phenotypes such as coded protein sequence or gene expression, which in turn affect BP variability. Therefore, characterizing genes whose expression is associated with BP may reveal cellular processes involved in BP regulation and uncover how transcripts mediate genetic and environmental effects on BP variability. A meta-analysis of results from six studies of global gene expression profiles of BP and hypertension in whole blood was performed in 7017 individuals who were not receiving antihypertensive drug treatment. We identified 34 genes that were differentially expressed in relation to BP (Bonferroni-corrected p<0.05). Among these genes, FOS and PTGS2 have been previously reported to be involved in BP-related processes; the others are novel. The top BP signature genes in aggregate explain 5%-9% of inter-individual variance in BP. Of note, rs3184504 in SH2B3, which was also reported in GWAS to be associated with BP, was found to be a trans regulator of the expression of 6 of the transcripts we found to be associated with BP (FOS, MYADM, PP1R15A, TAGAP, S100A10, and FGBP2). Gene set enrichment analysis suggested that the BP-related global gene expression changes include genes involved in inflammatory response and apoptosis pathways. Our study provides new insights into molecular mechanisms underlying BP regulation, and suggests novel transcriptomic markers for the treatment and prevention of hypertension

    A meta-analysis of gene expression signatures of blood pressure and hypertension

    Get PDF
    Genome-wide association studies (GWAS) have uncovered numerous genetic variants (SNPs) that are associated with blood pressure (BP). Genetic variants may lead to BP changes by acting on intermediate molecular phenotypes such as coded protein sequence or gene expression, which in turn affect BP variability. Therefore, characterizing genes whose expression is associated with BP may reveal cellular processes involved in BP regulation and uncover how transcripts mediate genetic and environmental effects on BP variability. A meta-analysis of results from six studies of global gene expression profiles of BP and hypertension in whole blood was performed in 7017 individuals who were not receiving antihypertensive drug treatment. We identified 34 genes that were differentially expressed in relation to BP (Bonferroni-corrected p<0.05). Among these genes, FOS and PTGS2 have been previously reported to be involved in BP-related processes; the others are novel. The top BP signature genes in aggregate explain 5%-9% of inter-individual variance in BP. Of note, rs3184504 in SH2B3, which was also reported in GWAS to be associated with BP, was found to be a trans regulator of the expression of 6 of the transcripts we found to be associated with BP (FOS, MYADM, PP1R15A, TAGAP, S100A10, and FGBP2). Gene set enrichment analysis suggested that the BP-related global gene expression changes include genes involved in inflammatory response and apoptosis pathways. Our study provides new insights into molecular mechanisms underlying BP regulation, and suggests novel transcriptomic markers for the treatment and prevention of hypertension
    • …
    corecore